Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

52.62
Delayed Data
As of Dec 15
 +1.06 / +2.06%
Today’s Change
46.43
Today|||52-Week Range
63.40
-5.33%
Year-to-Date

Today’s Trading

Previous close51.56
Today’s open51.51
Day’s range51.15 - 52.89
Volume2,641,459
Average volume (3 months)869,159
Market cap$8.1B
Data as of 4:00pm ET, 12/15/2017

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+151.44%
Earnings growth (next 5 years)+57.70%
Revenue growth (last year)+18.68%
P/E ratioNM
Price/Sales11.29
Price/Book6.63

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+1.93+1.56%
SGENSeattle Genetics Inc+0.73+1.41%
TSROTESARO Inc-3.29-3.92%
JAZZJazz Pharmaceuticals...+0.03+0.02%
Data as of 4:00pm ET, 12/15/2017

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)$0.20
Annual revenue (last year)$745.7M
Annual profit (last year)-$208.4M
Net profit margin-27.95%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts